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Abstract: The glucocorticoid receptor (GR) protein is a cytosolic ligand-depen-
dent transcription factor with numerous functions regulated by post-transla-
tional modifications, including phosphorylation/dephosphorylation. Among the 
functions most extensively affected by GR phosphorylation are the modulation 
of its transcriptional activity, alterations in its interaction pattern with cofac-
tors, nuclear translocation and selective gene transactivation. Intensive analysis 
of the intracellular distribution of GR phosphoisoforms and their interaction with 
proteins of other cellular signalling networks required the use of [γ-32P]ATP as 
a phosphate donor, and special laboratory protection measures to avoid external 
irradiation and contamination. In the present study, simple and easy-to-use 
non-radioactive protein mobility shift assays (NMS assays) were developed 
using one- and/or two-dimensional gel electrophoresis based on differences in 
the pI and molecular mass of GR phosphoisoforms. The GR isoforms were im-
munodetected with specific monoclonal or polyclonal anti-GR antibodies by 
Western blot in three diverse systems, namely yeast BJ2168 cells expressing 
wild-type rat GR, rat hepatoma GRH2 cells grown in culture and brain tissue 
from Wistar rat experimental animals. The results obtained using the NMS as-
say were similar to previous results obtained with the [γ-32P] ATP standard assay. 
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INTRODUCTION 
The glucocorticoid receptor (GR) protein is a ligand-dependent transcript-
tional factor which, in the absence of glucocorticoid hormones (GCs), is located 
primarily in the cytoplasm of the target cell in the form of a hetero-oligomeric 
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complex with heat shock proteins (HSPs).1,2 After binding to GCs, the GR un-
dergoes conformational changes, dissociates from the HSPs, homodimerizes and 
translocates into the nucleus where it interacts directly with its specific DNA se-
quences in the promoter region of the target genes.1 In addition, the activated GR 
may interact with other transcription factors, such as the nuclear factor-κB, the 
activator protein-1 and many others, via protein–protein interactions, thus influ-
encing indirectly the activity of these transcription factors on their target genes.3,4 
Phosphorylation is a very important post-translational modification of GR, 
regulated by cellular enzymes kinases and phosphatases, influencing and modu-
lating virtually all of the GR functions.5,6 The N-terminal domain of rat GR con-
tains phosphorylation sites at the amino acids serine 224/232 and serine 246, acti-
vated by cyclin-dependent kinases (CDKs) and c-Jun-N-terminal kinase (JNK), 
respectively.7,8 GR phosphorylation by these kinases affects its transcriptional 
activity, protein stability and nucleo-cytoplasmic shuttling, thus modulating GR-me-
diated gene expression.5,9,10 For an understanding of the physiological functions 
of GR, it is of crucial importance to have simple and accurate method(s) for ana-
lysis of the phosphoisoforms of GR. Such methods would enable studies of intra-
cellular distribution of GR phosphoisoforms and their interaction with proteins of 
other cellular signalling networks. Most of the recently used methods employed 
radioactively labelled phosphate donor [γ-32P]ATP to follow GR phosphorylation 
in vivo or in vitro.7–10 Although powerful, these techniques required special labo-
ratory protection protocols due to possible external irradiation and contamination 
by the high levels of [γ-32P]ATP radioactivity.7,10 
In the present study, simple and easy-to-use non-radioactive protein mobility 
shift assays (NMS assays) were developed for the analysis of GR phosphoiso-
forms based on the differential mobility of GR phosphoisoforms separated by the 
one- or two-dimensional gel electrophoresis. The hyperphosphorylated GR iso-
form was detected by highly specific monoclonal anti-GR antibodies or epitope 
specific polyclonal antibodies by Western blot immunodetection assay. The NMS 
assays were first established in vivo with yeast Saccharomyces cerevisiae BJ2168 
strain expressing wild-type rat GR and thereafter successfully applied to test in 
vivo phosphorylation of GR in rat hepatoma GRH2 cells grown in culture or 
brain tissue from Wistar rat experimental animals. The obtained results suggest 
that NMS assays can be used across very different biological systems from yeast 
cell to in vivo animal models with high sensitivity and reproducibility and 
provide an alternative way to study this subject and avoid using [γ-32P]ATP.7,10 
EXPERIMENTAL 
Baker’s yeast Saccharomyces cerevisiae strains and plasmids 
The triple protease deficient yeast strain BJ2168 (a, pep 4-3, prc 1-417, prb 5-1122, ura 
3-52, trp 1, leu 2)11 served as the parent for derivative strains containing various 2μ-origin- 
-based expression and reporter vectors. Transformations were performed by the lithium ace-
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tate procedure.12 The yeast expression plasmid pG-N79513,14 contained rat GR cDNA driven 
by the yeast glyceraldehyde-3-phosphate dehydrogenase promoter, residing on a 2μ vector 
(10–40 copies per cell) bearing the TRP1 selectable marker. The 2μ vector carries the URA3 
selectable marker, a bacterial origin of replication and the bacterial ampicillin resistance 
gene.14 Yeast cultures were propagated at 30 °C in minimal yeast medium supplemented with 
a standard mixture of amino acids and 2 % glucose.15 
Mammalian cells culture 
The mammalian cell line GRH2, a derivative of transfected hepatoma HTC cells, ex-
pressing a high level GR was used in the study.16 Cells were grown in 90 % Dulbecco’s 
modified Eagle’s medium H-16, supplemented with 10 % heat-inactivated FCS, 100 IU/mL 
penicillin and streptomycin and 2 mM L-glutamine (all obtained from Sigma-Aldrich, Tauf-
kirchen, Germany) in 95 % humidity atmosphere of 95 % air and 5 % CO2 at 37 °C. 
Hormone treatment and preparation of yeast and GRH2 cell extracts 
Yeast and GRH2 cells were treated in vivo with 10 μM deoxycorticosterone (DOC, 3300 
ng/mL medium) or 10 μM dexamethasone (Dex, 3900 ng/mL medium), respectively. The 
yeast cell extract was prepared (1:2 mass/volume) at 4 °C by glass bead lysis in 45 mM Hepes 
pH 7.4, containing 10 % glycerol, 1 mM Na2EDTA, 400 mM NaCl, 1 mM DTT and 0.5 % 
Nonidet P40 followed by centrifugation at 13,000 rpm in a Beckman JA centrifuge. When 
indicated, the supernatant was treated for 30 min at 25 °C with 20 IU/mL of calf intestine 
phosphatase (Boehringer Mannheim). The GRH2 cell extract was prepared in the same 
manner as the yeast extract except that the glass beads were omitted. 
Preparation of cell extracts from brain cortex of experimental animals 
Wistar males (2 months old, body mass 250 g) were exposed to acute stress (immobili-
zation),17 sacrificed by decapitation and the prefrontal brain cortex (PFC) was weighed and 
homogenized (1:2 mass/volume) at 4 °C in 20 mM Tris HCl buffer pH 7.2, containing 10 % 
glycerol, 1 mM Na2EDTA, 1 mM Na2EGTA, 50 mM NaCl, 2 mM DTT and protease inhi-
bitors.17 The homogenate was centrifuged at 38000 rpm for 60 min at 4 °C and the resulting 
supernatant was used as cell cytosol. 
The protein concentration in the yeast and mammalian cell extracts or brain cell cytosol 
was determined by the method of Lowry.18 
Separation and analysis of samples by one-dimensional gel electrophoresis (1-DE) or 
two-dimensional gel electrophoresis (2-DE) 
For analysis by 1-DE, samples (60 μg of protein) were mixed (1:1) in denaturing buffer 
according to Laemmli19 and separated by molar mass (Mm) in 7.5 % slab polyacrylamide gels 
for 45 min at 100 V under denaturing conditions. Standard mixture of Mm marker proteins 
(Sigma SDS6H2), containing: equine myosine (220000 g/mol), Escherichia coli β-galactosi-
dase (116000 g/mol), rabbit muscle phosphorylase B (97400 g/mol), bovine albumin (66000 
g/mol) and egg white ovalbumin (45000 g/mol), was used for 1-D gel calibration. 
In 2-DE, samples (100 μg of protein) were first mixed with isofocusing buffer (9 M urea, 
2 % Triton X-100, 5 % β-mercaptoethanol, 2 % of ampholines (4 volumes of ampholine pH 
5–7 plus 1 volume of ampholine pH 3–10) and 0.1 % Bromphenol Blue), and separated accor-
ding to isoelectric point (pI) in prefocused 4 % disk polyacrylamide gels. The gels were pre-
focused for 20 min at 200 V, then 20 min at 300 V and 20 min at 400 V before sample 
isofocusing was run for 10 min at 500 V and then 3.5 h at 750 V. For pI calibration, the 
following pI markers were run in parallel gel disks: soybean trypsin inhibitor (TI, pI = 4.6), 
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bovine carbonyl anhydrase (CA, pI = 5.9) and equine myoglobin (Myo, pI = 7.0). The sample 
disks were taken out of the glass tubes, incubated for 60 min in denaturing buffer according to 
Laemmli19 and layered on top of 7.5 % slab polyacrylamide denaturing gels (the same those 
used in 1-DE). The electrophoretic separation according to molar mass (Mm) was performed 
for 90 min at 120 V. 
Western blot immunodetection of GR protein 
Proteins separated by 1-DE or 2-DE were electrophoretically transferred to PVDF mem-
branes and blocked for 1 h at room temperature in phosphate buffered saline (PBS) containing 
5 % non-fat dry milk. Immunopositive bands were detected either with GR-specific BUGR2 
(gift from Professor Keith R. Yamamoto) monoclonal antibody or with M-20 (sc-1004, Santa 
Cruz Biotechnology) polyclonal antibody, both prepared in PBST (PBS, 0.1 % Tween 20, 2.5 % 
milk). After extensive washing (3–5 times for 10 min in PBST), the immunopositive bands 
were visualized by secondary goat-anti mouse or goat-anti rabbit antibody linked to alkaline 
phosphatase (ALP)20 or horseradish peroxidase chemiluminescences (ECL) detection system.17 
RESULTS AND DISCUSSION 
An electrophoretic mobility shift assay, also called “gel shift assay”, is a com-
mon technique usually used to study protein–DNA or protein–RNA interactions by 
1-D electrophoresis (1-DE). In the present report, it is shown that 1-DE and 2-DE 
methods can also be successfully applied for monitoring the phosphorylation or 
dephosphorylation of a single protein, i.e., glucocorticoid receptor (GR) isolated 
from yeast Saccharomyces cerevisiae cells or mammalian cells. As may be ob-
served in Fig. 1A (lanes 1, 3 and 5), the native unliganded GR expressed in yeast 
(S. cerevisiae strain BJ2168) resolved by 1-DE was detected by Western blot 
using specific anti-GR monoclonal antibodies (BUGR) as a single protein band 
corresponding to the position of the phosphorylase B marker at 97400 g/mol. 
Upon addition of the yeast GR specific hormone analogue deoxycorticosterone 
(10 µM, i.e., 3300 ng DOC/mL medium, Kd 4 nM),15,21 a “smeared” GR pattern 
appeared with a GR band corresponding to Mm of about 99000 g/mol (99kGR) 
(Fig. 1A, lanes 2, 4 and 6). The shift in the Mm of GR was observed in the inter-
val of 50–100 µg of total proteins assayed per lane (Fig. 1A, ALP detection) up 
to 200 µg of total proteins assayed (Fig. 1B, ECL detection). Earlier studies3,10 in 
S. cerevisiae BJ2168 mutant strains carrying the GR serine 232 site targeted by 
CDK for phosphorylation mutated to alanine showed that the ligand-dependent 
shift in the Mm of GR corresponds to its hyper-phosphorylated form.3,10 In order 
to check if the 99kGR was actually a hyper-phosphorylated form of the GR, a 
control experiment in which BJ2168 extract was treated in vitro with 20 IU/mL 
of calf intestine phosphatase was performed (Fig. 1B). As may be observed, the li-
gand-dependent 99kGR was not present after the phosphatase treatment (Fig. 1B, 
lane 4). This fact complements and extends previous findings10 and provides a 
strong indication that 99kGR band was indeed the hyper-phosphorylated isoform 
of GR. 
2009 Copyright (CC) SCS
 DETECTION OF GLUCOCORTICOID PHOSPHOISOFORMS 241 
 
 
Fig. 1. Western blot analysis of yeast BJ2168 ectopically expressing GR separated by 1-DE. 
A) Titration of protein concentration 50, 75 or 100 μg and mobility shift: controls (lanes 1, 3, 
and 5), and yeast GR after hormone treatment (lanes 2, 4 and 6). B) Mobility shift sensitivity 
to phosphatase treatment: controls (lanes 1 and 3), yeast GR after hormone treatment (lanes 2 
and 4) and after calf intestine phosphatase (lanes 3 and 4). The position of molar mass 
standard (Std. Mm) phosphorylase B (97400 g/mol) is indicated by an arrow. 
When untreated or DOC treated BJ2168 extracts were resolved by 2-DE (1- 
-isoelectrofocusing and 2-separation according to molar mass) and screened by 
BUGR, both pI and Mm shifts were observed (Fig. 2, left and right panels, res-
pectively). The ligand-bound, hyper-phosphorylated and activated form of GR22 
was shifted towards both higher Mm and more acidic pI. The same 2-DE analysis 
was performed with GRH2 cell extracts after in vivo treatment with 10 μM Dex 
(3900 ng Dex /mL medium, Kd 4nM,23 Fig. 3). A similar, although less pronoun-
ced, shift in the Mm and pI of GR was observed, indicating that GR phosphoiso-
forms may be also analysed by the 2-DE of rat hepatoma GRH2 cells in culture. 
Finally, GR phosphorylation was assayed by the 1-DE shift-assay in extracts 
isolated from Wistar rat brain tissue. The prefrontal brain cortex extracts which 
contain high levels of GR protein24 were prepared from control animals in which 
the natural hormone corticosterone (CORT) was at a low diurnal level, i.e., 130 
ng/mL plasma (Fig. 4, lane 1). The cytosol was also prepared from stressed ani-
mal brain corresponding to 630 ng of CORT/mL plasma (Fig. 4, lane 2). The 
1-DE analysis followed by Western blot detection of GR by specific M-20 poly-
clonal antibodies clearly showed the appearance of both 97.4kGR and 99kGR 
hormone-dependent hyperphosphorylated isoform under high CORT conditions. 
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These results provide evidence that the employed method may be successfully 
applied to separate these phosphoisoforms in vivo in whole animal studies. More-
over, in recent publication in which serine 232 epitope specific anti-GR antibo-
dies were used, the hyperphosphorylated isoform with reduced mobility (99kGR) 
was shown to be a CDK phosphorylated form of GR in Wistar rat brain.17 
Fig. 2. Western blot analysis of yeast 
BJ2168 ectopically expressing GR sepa-
rated by 2-DE. Left panel: the control 
sample; right panel: the sample treated 
with hormone. The positions of the pI 
standards: soybean trypsin inhibitor (TI, 
pI = 4.6), bovine carbonic anhydrase 
(CA, pI = 5.9) and equine myoglobin 
(Myo, pI = 7.0), and the position of the 
molar mass standard (Std. Mm) phos-
phorylase B (97400 g/mol) are indicated 
by dashed lines. 
Fig. 3. Western blot analysis of the GR 
from rat liver GRH2 cells separated by 
2-DE. Left panel: the control sample; 
right panel: the sample treated with hor-
mone (10 μM Dex). The position of the 
pI standards: soybean trypsin inhibitor 
(TI, pI = 4.6), bovine carbonic anhyd-
rase (CA, pI = 5.9) and equine myoglo-
bin (Myo, pI = 7.0), and the position of 
the molar mass standard (Std. Mm) phos-
phorylase B (97400 g/mol) are indicated 
by dashed lines. 
 
Fig. 4. Western blot analysis by specific 
M-20 antibodies of the GR from the pre-
frontal cortex of Wistar rat brain sepa-
rated by 1-DE: control sample with low 
hormone level (130 ng/mL CORT) (La-
ne 1) and a stressed animal with a high 
hormone level (630 ng/mL CORT), (La-
ne 2). The position of the molar mass 
standard (Std. Mm) phosphorylase B 
(97400 g/mol) is indicated by an arrow. 
CONCLUSIONS 
The non-radioactive electrophoretic protein mobility shift assays (NMS as-
says) used in the present study are equivalent to a standard radioactivity based as-
say using [γ-32P]ATP as a phosphate donor. Instead of the radioactivity detection 
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method, the NMS assay is based on Western blot immunodetection of GR phos-
phoisoform separated in one- and/or two dimensional gels according to differen-
ces in pI and molar mass. The GR forms are easily detected in all the studied 
biological systems and GR undergoes hormone dependent phosphorylation in 
yeast as well as in mammals, suggesting the importance and conservation of this 
process. In addition, these GR isoforms can be detected and quantified with high 
sensitivity and reproducibility, thus enabling the avoidance of the use of the 
[γ-32P]ATP assay; and the method does not require special laboratory protection 
measures. The NMS assay may be used to analyse GR from the diverse biolo-
gical systems: yeast cells, mammalian cells (rat hepatoma GRH2 culture) and brain 
tissue from experimental animals. 
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И З В О Д  
«WESTERN BLOT» АНАЛИЗА ФОСФОИЗОФОРМИ ГЛУКОКОРТИКОИДНОГ 
РЕЦЕПТОРА ПОМОЋУ ЈЕДНОДИМЕНЗИОНАЛНЕ И ДВОДИМЕНЗИОНАЛНЕ 
ЕЛЕКТРОФОРЕЗЕ 
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Manchester, Manchester, United Kingdom 
Глукокортикоидни рецептор (ГР) је цитосолни лиганд-зависни транскрипциони фактор 
чије бројне функције су регулисане пост-транслационим модификацијама: фосфорилацијом 
и дефосфорилацијом. Међу функцијама ГР које су најосетљивије на фосфорилацију су: мо-
дулација његове транскрипционе активности, промене у начину интеракције са кофакто-
рима, транслокација ГР у једро и селективна трансактивација гена. У литератури су до сада 
описане бројне анализе унутарћелијске дистрибуције ГР и његове интеракције са протеи-
нима других сигналних путева, које су засноване на [γ-32P]АТP као донору фосфатне групе. 
За овакве анализе потребне су специјалне лабораторијске мере заштите од зрачења и радио-
активне контаминације. У приказаној студији развили смо једноставан и лак нерадиоактивни 
тест («NMS») за анализу ГР фосфоизоформи који се заснива на промени у њиховој покрет-
љивости у једнодимензионалној или дводимензионалној електрофорези, као последици раз-
лика у pI и молекулској маси. Фосфоизоформе ГР су анализиране у три различита биолошка 
система: у квасцу BJ2186 са дивљим типом («wild-type») ГР, у ћелијама хепатома пацова 
GRH2 гајеним у култури и у можданом ткиву експерименталних Wistar пацова. Анализа 
фосфоизоформи ГР је рађена имунолошком методом помоћу високо-специфичних моно-
клонских или поликлонских антитела коришћених у «Western blot» тесту. Резултати до-
бијени «NMS» тестом били су слични нашим претходним резултатима у којима је коришћен 
стандардни [γ-32P]АТP тест. 
(Примљено 17. октобра 2007, ревидирано 27. августа 2008) 
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